Infant Bacterial Therapeutics AB(DE:9IB)
€6.26-0.30 (-4.57%)
DE:9IB
Infant Bacterial Therapeutics AB earnings date
€6.26
At close:-0.30 (-4.57%)
Infant Bacterial Therapeutics AB (9IB) Q3 2018 Earnings Report
4 Followers
DE:9IB Q3 2018 EPS Results
- Actual EPS
- -EUR 0.06
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.07
DE:9IB Q3 2018 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q3 2018
- Date
- 11/14/2018
- Time
- Before Open
- Conference Call
- Wednesday, November 14, 2018
DE:9IB Upcoming Earnings
Infant Bacterial Therapeutics AB's next earnings date is estimated for February 11, 2027, based on past reporting schedules.
Q3 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q3 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q3 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:9IB Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 11, 2027 | 2026 (Q4) | -0.07- | -0.13 | ― | ― |
| Nov 13, 2026 | 2026 (Q3) | -0.24-0.24 | -0.07 | -256.00% (-0.17) | |
| Aug 26, 2026 | 2026 (Q2) | -0.14-0.20 | -0.13 | -55.31% (-0.07) | |
| May 06, 2026 | 2026 (Q1) | -0.13-0.15 | -0.11 | -36.93% (-0.04) | |
| Feb 06, 2026 | 2025 (Q4) | -1.30-0.13 | -0.23 | 42.94% (+0.10) | |
| Nov 13, 2025 | 2025 (Q3) | ―-0.07 | -0.22 | 69.06% (+0.15) | |
| Aug 20, 2025 | 2025 (Q2) | ―-0.13 | -0.29 | 55.08% (+0.16) | |
| May 07, 2025 | 2025 (Q1) | ―-0.11 | -0.19 | 39.81% (+0.07) | |
| Feb 13, 2025 | 2024 (Q4) | ―-0.23 | -0.27 | 17.43% (+0.05) | |
| Nov 14, 2024 | 2024 (Q3) | ―-0.22 | -0.21 | -4.94% (-0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

